This JAMA Forum discusses the ways that policymakers can use different metrics that are more meaningful to patients when measuring patient access to treatment in the Medicaid program.
No takes yet. Share an insight, caveat, or question.
Sommers et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: